All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast.

Optical molecular imaging in small animals harnesses the power of highly specific and biocompatible contrast agents for drug development and disease research1-7. However, the widespread adoption of in vivo optical imaging has been inhibited by its inability to clearly resolve and identify targeted internal organs. Optical tomography8-11 and combined X-ray and micro-computed tomography (micro-CT)12 approaches developed to address this problem are generally expensive, complex or incapable of true anatomical co-registration. Here, we present a remarkably simple all-optical method that can generate co-registered anatomical maps of a mouse's internal organs, while also acquiring in vivo molecular imaging data. The technique uses a time series of images acquired after injection of an inert dye. Differences in the dye's in vivo biodistribution dynamics allow precise delineation and identification of major organs. Such co-registered anatomical maps permit longitudinal organ identification irrespective of repositioning or weight gain, thereby promising greatly improved accuracy and versatility for studies of orthotopic disease, diagnostics and therapies.

[1]  G. Drummond,et al.  Clearance of indocyanine green as an index of liver function during cyclopropane anaesthesia and induced hypotension. , 1976, British journal of anaesthesia.

[2]  J. Gerring A case study , 2011, Technology and Society.

[3]  MR image time-intensity relations in spleen and kidney: a comparative study of GdDTPA, albumin-(GdDTPA), and Gd2O3 colloid. , 1990, American journal of physiologic imaging.

[4]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[5]  M. P. Hayball,et al.  Colour perfusion imaging: a new application of computed tomography , 1991, The Lancet.

[6]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis. , 1995, The American surgeon.

[7]  Intact tissue of gastrointestinal cancer specimen orthotopically transplanted into nude mice. , 1998, Hepato-gastroenterology.

[8]  Eva M. Sevick-Muraca,et al.  Pharmacokinetics of ICG and HPPH-car for the Detection of Normal and Tumor Tissue Using Fluorescence, Near-infrared Reflectance Imaging: A Case Study¶ , 2000, Photochemistry and photobiology.

[9]  R. Weissleder A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[10]  Robert E. Lenkinski,et al.  In vivo near-infrared fluorescence imaging of osteoblastic activity , 2001, Nature Biotechnology.

[11]  C H Schmitz,et al.  Optical tomographic imaging of dynamic features of dense-scattering media. , 2001, Journal of the Optical Society of America. A, Optics, image science, and vision.

[12]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[13]  Anthony J. Durkin,et al.  In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. , 2003, Applied optics.

[14]  J. Ripoll,et al.  In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. , 2003, Medical physics.

[15]  J. Ripoll,et al.  Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Moore,et al.  Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. , 2004, Diabetes.

[17]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[18]  D. Jenkins,et al.  Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice , 2005, Breast Cancer Research.

[19]  Anna Moore,et al.  In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe , 2004, Cancer Research.

[20]  Vasilis Ntziachristos,et al.  Volumetric tomography of fluorescent proteins through small animals in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Andreas H Hielscher,et al.  Optical tomographic imaging of small animals. , 2005, Current opinion in biotechnology.

[22]  Markus Rudin,et al.  In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe , 2005, Nature Biotechnology.

[23]  Richard M Levenson,et al.  Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. , 2005, Journal of biomedical optics.

[24]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[25]  W. D. Martin,et al.  A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals. , 2005, Journal of molecular endocrinology.

[26]  J. Culver,et al.  Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice. , 2005, Optics express.

[27]  Eva M. Sevick-Muraca,et al.  Quantifying molecular specificity of αvβ3 integrin-targeted optical contrast agents with dynamic optical imaging , 2005 .

[28]  Jianhua Xuan,et al.  Modeling and Reconstruction of Mixed Functional and Molecular Patterns , 2006, Int. J. Biomed. Imaging.

[29]  B. Pogue,et al.  Spectrally resolved bioluminescence optical tomography. , 2006, Optics letters.

[30]  Anna Moore,et al.  In vivo imaging of islet transplantation , 2006, Nature Medicine.

[31]  M S Patterson,et al.  Quantification of bioluminescence images of point source objects using diffusion theory models , 2006, Physics in medicine and biology.

[32]  Ozlem Birgul,et al.  Combined Diffuse Optical Tomography (DOT) and MRI System for Cancer Imaging in Small Animals , 2006, Technology in cancer research & treatment.